Abbott’s TactiCath Contact Force Ablation Catheter Receives FDA’s Approval for Atrial Fibrillation (AFib)

 Abbott’s TactiCath Contact Force Ablation Catheter Receives FDA’s Approval for Atrial Fibrillation (AFib)

Abbott’s TactiCath Contact Force Ablation Catheter Receives FDA’s Approval for Atrial Fibrillation (AFib)

Shots:

  • TactiCath is a sensor-enabled ergonomic designed catheter used for providing precise heart images while performing ablation procedures in real-time electrical activity
  • The approval leads to expansion of Abbott’s portfolio with EnSite Precision cardiac mapping system in combination with TactiCath allowing physicians to treat AFib
  • Abbott has three catheters with enabled sensors: Advisor HD Grid Mapping Catheter, FlexAbility Ablation Catheter including TactiCath which is being evaluated in 84 countries WW

Click here to read full press release/ article | Ref: Abbott | Image: Medical Product Sourcing